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The genetic and phenotypic diversity of cells within tumors is
a major obstacle for cancer treatment. Because of the stochas-
tic nature of genetic alterations, this intratumoral heterogene-
ity is often viewed as chaotic. Here we show that the altered
metabolism of cancer cells creates predictable gradients of extra-
cellular metabolites that orchestrate the phenotypic diversity of
cells in the tumor microenvironment. Combining experiments and
mathematical modeling, we show that metabolites consumed
and secreted within the tumor microenvironment induce tumor-
associated macrophages (TAMs) to differentiate into distinct sub-
populations according to local levels of ischemia and their position
relative to the vasculature. TAMs integrate levels of hypoxia and
lactate into progressive activation of MAPK signaling that induce
predictable spatial patterns of gene expression, such as stripes of
macrophages expressing arginase 1 (ARG1) and mannose receptor,
C type 1 (MRC1). These phenotypic changes are functionally rele-
vant as ischemic macrophages triggered tube-like morphogenesis
in neighboring endothelial cells that could restore blood perfusion
in nutrient-deprived regions where angiogenic resources are most
needed. We propose that gradients of extracellular metabolites act
as tumor morphogens that impose order within the microenviron-
ment, much like signaling molecules convey positional information
to organize embryonic tissues. Unearthing embryology-like pro-
cesses in tumors may allow us to control organ-like tumor features
such as tissue repair and revascularization and treat intratumoral
heterogeneity.
cancer metabolism | tumor microenvironment | morphogens | positional
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Tumors displaya largedegreeofgeneticandphenotypichetero-geneity that hampers diagnosis and treatment (1–8). However,
tumors are capable of local organization and respond collectively
to signals from their microenvironment (9, 10). Examples include
the formation of multicellular structures such as blood vessels
(11, 12), coordinated collective invasion (13), noncell autonomous
paracrine effects (14), and “division of labor” between different
tumorcells(15).Howcanmulticellularorganizationemergewithin
heterogeneous and genetically diverse tumors?
Here we reveal that gradients of metabolites, formed by the
altered metabolism of cancer cells (16–18) and accentuated by
aberrant vascularization (11, 19–21), lead to predictable phe-
notypic diversity in the tumor microenvironment. This drives
temporal and spatial coordination of multiple cell types, includ-
ing tumor-associated macrophages (TAMs) that are known to
respond to extracellular metabolite levels (21–24). We propose
that the topology of the vasculature leads to local differences in
metabolite concentrations that provide spatial information that
can modulate the phenotypes of different cells in the tumor
microenvironment.
Results
Extracellular Metabolites Form Gradients That Convey Positional
Information in Tumors. To measure intratumoral cellular hetero-
geneity, while preserving information regarding tissue microar-
chitecture, we developed an image cytometry approach that com-
bines multiscale microscopy and image processing to extract
single-cell data, including spatial features such as distance to the
vasculature, for thousands of cells in tumor tissue cryosections
(Fig. 1A and Fig. S1 A–D). In a mouse model of breast tumor
[mouse mammary tumor virus–polyoma virus middle T-antigen
(MMTV-PyMT)] we found that gradients of hypoxia [labeled
with pimonidazole (PMO)] closely mirrored the topology of the
vasculature and, consistent with previous reports (12, 19–21), sat-
urated at∼100 µm from the closest blood vessel (Fig. 1 B and C).
We asked whether these gradients of metabolites could impose
patterned phenotypic changes in cells experiencing different
local conditions. We focused on TAMs, a major protumoral stro-
mal infiltrate (25–27) whose phenotypic state and viability can
be altered by metabolic stimuli (21–23). We measured levels
of selected markers associated with different TAM states and
investigated their relationship to local hypoxia levels and dis-
tance to the nearest vessel. Whereas some macrophage mark-
ers were expressed homogenously (Fig. S1E), the TAM markers
arginase 1 (ARG1) and mannose receptor, C type 1 (MRC1)
were expressed in distinct and spatially restricted subpopula-
tions (Fig. 1D). TAMs located in well-nourished regions, such
as cortical and perivascular areas, expressed MRC1 whereas
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Fig. 1. Spatial diversity in TAM phenotypes corre-
lates with metabolic gradients within tumors.
(A) Experimental approach to study metabolic and
cellular intratumoral heterogeneity. PMO (a hypoxia
marker) was injected into tumor-bearing mice to label
hypoxic tumor regions. Tumor cryosections were then
imaged at high magnification (typically at 200×),
achieving multiscale images. This enabled image pro-
cessing to obtain single-cell features for hundreds of
thousands of cells per section while maintaining their
spatial information. (B and C) The spatial distribution
of hypoxia mirrored the structure of the tumor vas-
culature from a distance. (B) Cryosections of MMTV-
PyMT tumors were stained with antibodies against
endothelial vascular cells (CD31) and hypoxic regions
(PMO). (B′) Image channels were split in a selected
field of interest to reveal the correlation between
hypoxia and distance from the vessel. This was quan-
tified in C (bars indicate SD, n= 6). (D and E) Pheno-
typic diversity of TAMs correlates with the topology of the vascular system. (D) Similar tissue sections were stained with antibodies against TAM mark-
ers (MRC1 and ARG1) and PMO (colocalization of ARG1 and PMO indicated by yellow arrows). (E) Image quantification of >105 individual cells within
tumor sections showed that ARG1 levels in TAMs were correlated with hypoxic regions (r = 0.6, P< 10−6) whereas MRC1-expressing TAMs were inversely
correlated with local hypoxic levels (r = -0.2, P< 10−6). Three sections of three tumors extracted from different animals were analyzed for each marker.
macrophages within hypoxic regions, far from the vascula-
ture, showed high ARG1 protein levels (Fig. 1 D and E).
The spatial segregation between ARG1HI and MRC1HI TAMs
was somewhat surprising because these markers are often
coexpressed by antiinflammatory macrophages that respond
to type 2 helper T-cell (Th2) signals and have been pro-
posed to share features with TAMs (26–29). We con-
firmed the correlation between hypoxia and the location of
ARG1HI TAMs in a mouse model of pancreatic neuroen-
docrine tumors [rat insulin promoter 1–T-antigen (RIP1-TAg2)]
(Fig. S1F), indicating that spatial patterning of TAM phenotypes
is a common feature of the tumor microenvironment.
Gradients of Oxygen and Lactate Orchestrate Spatial Patterns of
Cell Phenotypes. Our in vivo observations suggest a model where
extracellular metabolites specify different TAM subpopulations
across concentration gradients, similar to how morphogen gradi-
ents specify stripes of gene expression during embryonic develop-
ment (30–32). We then sought to investigate whether metabolite
gradients were sufficient to produce gene expression patterns in
TAMs. Traditional in vitro systems are spatially homogeneous
without major changes in metabolite distribution. To overcome
this, we developed an in vitro microphysiological system named
the metabolic microenvironment chamber (MEMIC) (Fig. 2A
and Fig. S2 A and B). MEMIC allows gradients of ischemia
to emerge spontaneously as a result of cellular activities such
as nutrient consumption and secretion of waste products. As a
proof of principle, we used MEMIC to generate and visualize
oxygen gradients in the hypoxic response of C6 glioma cells engi-
neered to express GFP under an HIF1α-responsive element (C6-
GFP-HRE) (21) (Fig. 2B).
To assess whether gradients of metabolites can pattern
macrophages in the MEMIC, we cultured bone marrow-derived
macrophages (hereafter referred to simply as macrophages) (SI
Materials and Methods) with C6-GFP-HRE cells. After 24 h,
macrophages showed spatial patterns of ARG1 protein levels
that correlated with GFP (hypoxia) and increased with the dis-
tance to the normoxic region (Fig. 2 C and D). In control
experiments lacking metabolite gradients, we did not observe
induction of ARG1 expression (Fig. 2D). Consistent with our
in vivo observations, MRC1 protein levels were inversely cor-
related with hypoxia and were higher in normoxic regions (Fig.
2E and Fig. S2C). These spontaneous expression patterns were
not dependent on the cancer cell type as MEMIC experiments
with macrophages cocultured with cell lines derived from the
PyMT and Rip-Tag2 tumor models used above, human cancer
cell lines (Fig. S2 C and D), or even macrophages cultured alone
(Fig. 2F) showed the same trend. We have recently shown that
extreme levels of ischemia are lethal for macrophages (21). Con-
sistently, ARG1 expression emerges as a stripe between well-
nurtured macrophages and the region where ischemic levels
become lethal (Fig. 2F). Together, these results demonstrate that
MEMIC experiments suggest that extracellular metabolite gradi-
ents play a key role in the phenotypic diversity of TAMs.
Gradual changes in metabolite concentration are somehow
translated into discrete stripes of gene expression patterns with
clear boundaries (Fig. 2F and Fig. S2C). To identify which
metabolites are setting these phenotypic boundaries, we focused
on the ischemic ARG1HI/MRC1LO macrophage subpopulation.
First, we wanted to separate the effect of hypoxia from other
ischemic conditions such as nutrient deprivation. To do this, we
cultured macrophages within a modified MEMIC where the top
cover was made permeable to oxygen but not to soluble metabo-
lites. In this scenario, ARG1 protein levels remained low across
the entire MEMIC, showing that hypoxia is necessary to produce
ARG1 patterns (Fig. 2G). To test whether hypoxia was sufficient
to induce ARG1, we cultured macrophages in regular culture
plates within a hypoxic chamber (1% oxygen) or under normal
cell culture conditions (21% oxygen). Surprisingly, we found no
effect of hypoxia in ARG1 levels, unless macrophages were cul-
tured at high cell densities (Fig. 2H), indicating that hypoxia was
necessary but not sufficient to pattern macrophages. This cell
density effect was not mediated by cell–cell contact because stim-
ulation of cell contact-sensing molecules (33) did not increase
ARG1 levels (Fig. S3A).
Consistent with previous evidence (22), we found extensive
evidence for the synergistic role of hypoxia and lactate. First,
the treatment of sparse macrophage populations with a com-
bination of hypoxia and culture media previously conditioned
by dense macrophage populations (cultured under hypoxia)
increased ARG1 levels (Fig. 2I). To determine the molecular
weight of the secreted signal, we fractionated the conditioned
media (3-kDa cutoff columns). This revealed that the low, but
not the high, molecular weight fraction of the conditioned media
increased ARG1 levels in sparse macrophage cultures, indicating
that the sensed factor was a small molecule (Fig. 2I). We there-
fore screened for different small molecules that could synergize
with hypoxia to increase ARG1 levels (Table S1). We found
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Fig. 2. Extracellular metabolic gradients are necessary and sufficient to produce striped expression domains and spatial patterning of macrophages.
(A) Schematic representation of the MEMIC chamber fabricated with 3D printing. This 12-well format contains an independent MEMIC replicate in each well.
(A′) Top view of one of those wells. (A′′) Detailed side view of a MEMIC where cells are cultured in a small chamber that connects to a large volume of fresh
media through a slit. Cell activities such as nutrient consumption and waste product secretion change the local nutrient composition within the small chamber
and generate spatial gradients; diffusion via the slit allows a constant exchange with the fresh media reservoir. Thus, cells proximal to this slit remain well
nurtured, whereas distal cells become progressively more ischemic. (B and C) Coculture of macrophages and a cancer cell line engineered to express GFP under
hypoxia (C6-HRE-GFP). (B) GFP hypoxia at 24 h reveals a spatial gradient. (C) In the same culture, spatial patterns of ARG1 in macrophages mirrored hypoxia
gradients (compare Insets C′ and C′′). (D) Image analysis at the single-cell level of macrophages cocultured with C6-HRE-GFP glioma cells in a conventional
in vitro system (without metabolite gradients, Left) or in the MEMIC (Right). ARG1HI macrophages are defined as expressing levels fivefold higher than the
median. (E) ARG1 levels increased with hypoxia whereas MRC1 levels decreased with hypoxia. (F–H) Hypoxia was necessary but not sufficient to trigger ARG1
expression. (F) Cancer cells were not required for the emergence of phenotypic patterns as macrophages cultured in the MEMIC alone displayed stripes of
ARG1 expression in sublethal levels of ischemia. (G) Spatial patterns of ARG1 expression in macrophage monocultures (Left). This effect required hypoxia as it
disappeared when O2 concentration was restored to environmental levels using a polydimethylsiloxane (PDMS) membrane (Right) that is permeable to gases.
(H) Hypoxia can induce the expression of ARG1 but only in high-density cultures, showing that it is necessary but not sufficient. (I) Low molecular weight
fraction of conditioned media collected from macrophages cultured under hypoxia can trigger ARG1 expression in sparse macrophage cultures. Conditioned
media were fractioned according to molecular weight (MW) with a 3-kDa cutoff. Note change of scale in y axis. (J) Lactate, which accumulated in the cell
culture media of hypoxic macrophages, increases with macrophage density (24 h culture at 1% O2). (K) Lactate showed a dose-dependent synergy in inducing
ARG1 levels with low O2. Lactate doses were chosen to cover the range between no lactate and high lactate doses typically used to study cellular response to
this molecule (21, 22, 48). Bars indicate SD from three biological replicates. Images are representative of selected lactate doses.
that the most potent inducer was lactate (Fig. S3B). Hypoxic
macrophages secreted lactate, which accumulated in the cell
culture media proportionally to the density of macrophages (Fig.
2J). When we treated normoxic and hypoxic macrophages with
a wide range of lactate doses, we saw a concomitant increase
of ARG1 protein levels in hypoxic macrophages but not in nor-
moxic ones, showing that lactate and hypoxia act as synergistic
cues to induce ARG1 expression (Fig. 2K). This effect is con-
sistent with recent evidence showing a similar effect of lactate
in transcription levels of Arg1 mRNA in TAMs (22). However,
in our experiments, lactate alone was not sufficient to trigger a
maximal Arg1 response at the protein level (Fig. 2K).
Lactic acid had similar effects to those of lactate but at high
concentrations it also affected macrophage viability due to media
acidification (21) (Fig. S3 C–E). Overall, our results showed that
a combination of low oxygen and high lactate was necessary and
sufficient to trigger the expression of ARG1 in macrophages.
These data suggest that opposing gradients of lactate and oxygen,
which are ubiquitous in solid tumors (19–21), create predictable
phenotypic patterns among TAMs. Because these gradients fol-
low the topology of the tumor vascular system (Fig. 1), it is pos-
sible that they convey positional information about the distance
to blood vessels.
Positional Information Is Interpreted via MAPK/ERK Signaling. We
then investigated how macrophages sensed the combination of
low oxygen and high lactate and integrated those signals into
phenotypic responses. We used RNA sequencing (RNA-seq) to
identify transcriptional differences between macrophages treated
with different levels of oxygen and/or high lactate (Fig. 3A and
Fig. S3 A–C). We first observed that transcriptional changes in
macrophages treated by oxygen/lactate did not display a consis-
tent change in gene expression of markers commonly used to char-
acterize macrophages as pro- or antiinflammatory (26–29) in a
consistent manner (Fig. S4C). The effect of metabolites, however,
did induce features of the Toll-like receptor 4 (TLR4)-induced
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macrophage response to LPS that signals via the MAPK pathway
(Fig. S4C andD), such asArg1 andNos2 coexpression (34). Rein-
forcing this observation, gene set enrichment analysis (GSEA) of
RNA-seq data revealed that macrophages cultured in low oxygen
and high lactate showed an enriched signature of KRAS/MAPK
signaling activation (Fig. 3A and Fig. S4F). Pharmacological per-
turbations further supported a role for the MAPK pathway by
showing that LPS increased ARG1 levels in hypoxic macrophages
specifically through this pathway (Fig. S4E–H).
If the MAPK pathway is interpreting positional information
brought by oxygen and lactate gradients, it should (i) be acti-
vated in a gradual manner and (ii) be required for the phenotypic
switch we observed in macrophages (35, 36). First, we observed a
strong correlation between phospho-ERK1/2 levels and the dis-
tance from the normoxic region (Fig. 3B) whereas total MAPK
(ERK1/2) levels remained constant (Fig. S4I). Inhibition of
MEK, a key member of this pathway, completely abrogated
ARG1 patterning (Fig. 3C). Similar results were obtained by
inhibiting the upstream MAPK component c-Raf with the Food
and Drug Administration (FDA)-approved inhibitor Sorafenib
as well as with the more selective GW5074 (Fig. S4K). Altogether
our data show that, by sensing lactate and oxygen levels, TAMs
can determine their position with respect to the vasculature (or
to the slit in the MEMIC). This positional information required
MAPK signaling and led to a predictable emergence of spatial
phenotypic diversity in macrophages.
Macrophages Relay Positional Information and Organize Morpho-
genetic Changes in Neighboring Cells. During embryogenesis, pat-
terned cells can elaborate and refine developmental programs
by relaying their positional information via the secretion of cell
signals that are sensed by adjacent cells (30–32). We thus hypoth-
esized that macrophages, conditioned by metabolic cues, can
relay their positional information to neighboring cells (Fig. 4A).
We thus compared cytokine secretion profiles of macrophages
treated with hypoxia and/or high levels of lactate. The combina-
tion of hypoxia and lactate increased secretion of the proangio-
genic cytokine VEGFA above all other 111 screened cytokines
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Fig. 3. Macrophages respond to gradients of extracellular metabolites,
using MAPK signaling. (A) RNA-seq revealed transcriptional changes of
macrophages cultured under different levels of metabolites. GSEA suggested
a strong enrichment of the KRAS/MAPK pathway. (B) KRAS signals via the
MAPK pathway and macrophages cultured in the MEMIC showed spatial pat-
terns of MAPK activation (ERK1/2 phosphorylation) correlated with ischemia.
(C) Representative images and single-cell–level quantification showing that
MAPK inhibition abrogates macrophage spatial patterns in the MEMIC.
(Fig. 4B). Quantification of secreted VEGFA, using a bead-
based ELISA (Fig. 4C), and of Vegfa mRNA levels, using quan-
titative PCR (qPCR) (Fig. S4D), showed that hypoxia increased
VEGFA secretion and that this effect was boosted by lactate,
indicating that hypoxia and lactate regulate macrophage cytokine
production in a synergistic manner (Fig. S4J).
To test whether these changes were functionally relevant,
we cocultured GFP-expressing macrophages with mCherry-
labeled SVEC4-10 endothelial (SVEC) cells embedded in a
matrigel/collagen I matrix layer (Fig. S5B). Under normal con-
ditions, these cocultures did not result in any evidence of vas-
culogenesis. In contrast, macrophages previously cultured under
low oxygen and high lactate levels were able to induce tube-like
morphogenesis in SVEC cells (Fig. S5B and Movie S1). Con-
trol experiments using hypoxia and lactate in the absence of
macrophages or in the presence of macrophages treated with
MAPK or VEGF inhibitors showed no vascular morphogenesis,
indicating that VEGFA, secreted by ischemic macrophages, was
required for the response of endothelial cells (Fig. S5C). These
data show that macrophages were able to relay information about
microenvironmental conditions to endothelial cells and to trigger
a modular and noncell autonomous process of tube-like morpho-
genesis in response to oxygen and lactate levels.
Positional Information Optimizes Angiogenesis and Leads to Faster-
Growing Tumors. Lactate and hypoxia increase with the distance
from the vasculature, suggesting that VEGFA levels should also
increase within ischemic regions. Using an agent-based model
that we developed to study this type of question (21), we pre-
dicted that VEGFA levels should indeed increase in ischemic
regions (Fig. 4D). Consistent with this, analysis of tumor sec-
tions in the MMTV-PyMT model revealed that hypoxic TAMs
expressed higher VEGFA levels than TAMs located in other
tumor regions (Fig. 4E). We also observed that within hypoxic
tumor regions, VEGFA-expressing TAMs were associated with
small groups of CD31+ endothelial cells that have not yet formed
into vessels (Fig. 4F). These endothelial cells stained positive for
the nascent capillary marker nestin (NES) (Fig. S5A). A simi-
lar scenario has been reported during nerve regeneration where
hypoxia triggers VEGFA secretion by resident macrophages that
then recruit endothelial cells required for revascularization and
repair (23, 37). Our data suggest that ischemic TAM subpop-
ulations secrete VEGFA to induce endothelial cells to initiate
the revascularization of nutrient-deprived tumor regions, which
in turn would promote tumor growth (Fig. 4G). In fact, the
metabolism of TAMs has been recently shown to control tumor
blood vessel morphogenesis and metastasis (24).
Is there any advantage for the tumor to maintain a spatially
regulated vascularization mechanism? How does it compare,
for example, to constitutive secretion of VEGFA that would
promote angiogenesis throughout the tumor? With the help of
mathematical modeling, we first simulated the growth of tumors
with a responsive angiogenic strategy, where the secretion of
proangiogenic factors (e.g., VEGFA) is modulated by extracel-
lular metabolites, which we compared with simulated tumors
that used a constitutive proangiogenic strategy. We assumed
that (i) the benefits of vascularization (i.e., nutrients, oxygen)
have diminishing returns on cell growth (i.e., excessive nutri-
ents no longer increase cell growth rate) and (ii) the forma-
tion of new vessels is a costly process. We implemented this
as an explicit cost, but it can also result from the increasing
resistance to flow in a dense vascular network (38). The ana-
lytical solution to this model revealed that the responsive strat-
egy always led to faster tumor growth rates even though the
total levels of VEGFA were higher in the constitutive model
(Fig. 4 H and I and Fig. S6A). More detailed agent-based
models confirmed these conclusions (Fig. S6 B–E, Movie S2,
and Fig. 4 J and K; model details in Supporting Information,
Mathematical Modeling). This result highlights that the spatial
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10 simulations. (L) Localized tube morphogenesis emerges within the MEMIC from a triple coculture of macrophages, endothelial cells (SVECs), and tumor
cells (TS1, unlabeled). L, Inset shows a representative magnified region.
distribution of signals can be more relevant for the progression
of the disease than its total levels, which could explain conflicting
outcomes in anti-VEGFA therapies (12, 39). Our model also
shows that tumors, by engaging with infiltrated macrophages, can
activate a mechanism of revascularization that allows the deliv-
ery of nutrients where they are most needed without wasting
resources in well-perfused tumor regions.
Our data and mathematical models suggest that proangio-
genic conditions are restricted to ischemic regions, which would
lead to local and responsive angiogenic strategies. To test this,
we took advantage of the MEMIC system to generate regions
of hypoxia in a triple coculture of PyMT-derived tumor cells,
macrophages, and SVEC endothelial cells. After 3 d of cul-
ture, SVEC cells formed well-structured tubes but only within
ischemic regions of the MEMIC (Fig. 4L). These data indicate
that macrophages indeed orchestrate tube-like morphogenesis in
regions where revascularization is most needed. More broadly,
this suggests that macrophages conditioned by metabolic gradi-
ents can relay spatial information to neighboring cells, triggering
functional adaptations to their local environment.
Discussion
Tumor progression is commonly seen as a deregulated, chaotic
process, yet our data suggest that gradients of metabolites act
as tumor morphogens and provide a local source of organiza-
tion by inducing phenotypic patterns in macrophages. This pro-
cess requires three simple conditions that are common in all solid
tumors: alterations in cell metabolism, aberrant vascularization,
and the presence of responsive stroma. These features lead to
gradients of metabolites that orchestrate a coordinated and spa-
tially organized angiogenic response.
It is possible that metabolite gradients also organize other
cell types within the tumor microenvironment, including other
immune cells (40–45) and malignant cells themselves. For exam-
ple, low glutamine levels found in blood-deprived necrotic tumor
cores lead to histone hypermethylation and dedifferentiation
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of cancer cells (46). Extracellular metabolite sensing is at the
core of biological organization and is conserved from bacteria to
mammals (47). Thus, we speculate that metabolites represented
the primal cues for positional information, which was then
coopted by signaling molecules during metazoan evolution.
Understanding the processes required for multicellular self-
organization in tumors may allow identification of targetable fea-
tures that are independent of specific genetic mutations and thus
less prone to therapeutic resistance.
Materials and Methods
Cells were cultured under standard conditions, using DMEM supplemented
with 10% (vol/vol) FBS. Images were acquired using an inverted wide-field
fluorescent microscope (Zeiss AxioObserver.Z1) and the images were pro-
cessed in Matlab, using custom-made analysis routines that are available
upon request. All animal studies were performed using protocols approved
by the Animal Care Committee at Memorial Sloan Kettering Cancer Center.
Details about the analytical solution to the theoretical model can be found
in SI Materials and Methods.
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